TENX Annual CFO
-$5.90 M
+$5.49 M+48.16%
31 December 2023
Summary:
As of January 23, 2025, TENX annual cash flow from operations is -$5.90 million, with the most recent change of +$5.49 million (+48.16%) on December 31, 2023. During the last 3 years, it has risen by +$3.37 million (+36.34%). TENX annual CFO is now -925.45% below its all-time high of -$575.70 thousand, reached on April 30, 1998.TENX Cash From Operations Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TENX Quarterly CFO
-$3.09 M
-$56.20 K-1.85%
30 September 2024
Summary:
As of January 23, 2025, TENX quarterly cash flow from operations is -$3.09 million, with the most recent change of -$56.20 thousand (-1.85%) on September 30, 2024. Over the past year, it has increased by +$2.08 million (+40.23%). TENX quarterly CFO is now -133.46% below its all-time high of $9.23 million, reached on April 30, 2002.TENX Quarterly CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TENX TTM CFO
-$12.46 M
-$1.01 M-8.79%
30 September 2024
Summary:
As of January 23, 2025, TENX TTM cash flow from operations is -$12.46 million, with the most recent change of -$1.01 million (-8.79%) on September 30, 2024. Over the past year, it has dropped by -$3.11 million (-33.33%). TENX TTM CFO is now -266.75% below its all-time high of $7.47 million, reached on January 31, 2003.TENX TTM CFO Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TENX Cash From Operations Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +48.2% | +40.2% | -33.3% |
| 3 y3 years | +36.3% | -234.5% | -62.5% |
| 5 y5 years | -7.3% | -234.5% | -62.5% |
TENX Cash From Operations High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | at high | +48.2% | -234.5% | +40.2% | -111.0% | +0.1% |
| 5 y | 5-year | at high | +48.2% | -234.5% | +40.2% | -111.0% | +0.1% |
| alltime | all time | -925.5% | +62.8% | -133.5% | +69.8% | -266.8% | +26.8% |
Tenax Therapeutics Cash From Operations History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | -$3.09 M(+1.9%) | -$12.46 M(+8.8%) |
| June 2024 | - | -$3.03 M(-41.3%) | -$11.45 M(+22.6%) |
| Mar 2024 | - | -$5.17 M(+339.8%) | -$9.34 M(+58.3%) |
| Dec 2023 | -$5.90 M(-48.2%) | -$1.17 M(-43.6%) | -$5.90 M(-8.0%) |
| Sept 2023 | - | -$2.08 M(+125.5%) | -$6.42 M(-16.3%) |
| June 2023 | - | -$923.00 K(-46.5%) | -$7.67 M(-24.6%) |
| Mar 2023 | - | -$1.72 M(+2.1%) | -$10.18 M(-10.6%) |
| Dec 2022 | -$11.39 M(+4.9%) | -$1.69 M(-49.3%) | -$11.39 M(-8.7%) |
| Sept 2022 | - | -$3.33 M(-2.9%) | -$12.47 M(+2.5%) |
| June 2022 | - | -$3.43 M(+16.8%) | -$12.16 M(+15.0%) |
| Mar 2022 | - | -$2.94 M(+6.1%) | -$10.57 M(-2.6%) |
| Dec 2021 | -$10.86 M(+17.1%) | -$2.77 M(-8.4%) | -$10.86 M(+7.8%) |
| Sept 2021 | - | -$3.02 M(+63.8%) | -$10.08 M(+6.7%) |
| June 2021 | - | -$1.85 M(-42.7%) | -$9.44 M(-3.9%) |
| Mar 2021 | - | -$3.22 M(+62.1%) | -$9.82 M(+5.9%) |
| Dec 2020 | -$9.27 M(+22.7%) | -$1.99 M(-16.7%) | -$9.27 M(+2.9%) |
| Sept 2020 | - | -$2.39 M(+7.0%) | -$9.01 M(+7.2%) |
| June 2020 | - | -$2.23 M(-16.6%) | -$8.41 M(+3.9%) |
| Mar 2020 | - | -$2.67 M(+54.7%) | -$8.09 M(+7.1%) |
| Dec 2019 | -$7.56 M(+37.4%) | -$1.73 M(-3.1%) | -$7.56 M(+7.5%) |
| Sept 2019 | - | -$1.78 M(-6.9%) | -$7.03 M(+3.3%) |
| June 2019 | - | -$1.91 M(-10.2%) | -$6.80 M(+12.0%) |
| Mar 2019 | - | -$2.13 M(+78.1%) | -$6.07 M(+10.4%) |
| Dec 2018 | -$5.50 M(-54.7%) | -$1.20 M(-23.0%) | -$5.50 M(-1.5%) |
| Sept 2018 | - | -$1.56 M(+31.0%) | -$5.58 M(+6.3%) |
| June 2018 | - | -$1.19 M(-23.8%) | -$5.25 M(-45.6%) |
| Mar 2018 | - | -$1.56 M(+21.6%) | -$9.66 M(-20.4%) |
| Dec 2017 | -$12.14 M(-23.5%) | -$1.28 M(+4.6%) | -$12.14 M(-13.1%) |
| Sept 2017 | - | -$1.23 M(-78.1%) | -$13.96 M(-18.0%) |
| June 2017 | - | -$5.60 M(+38.6%) | -$17.02 M(+2.6%) |
| Mar 2017 | - | -$4.04 M(+30.0%) | -$16.59 M(+4.5%) |
| Dec 2016 | -$15.87 M(+77.3%) | -$3.11 M(-27.5%) | -$15.87 M(+24.3%) |
| Sept 2016 | - | -$4.28 M(-17.1%) | -$12.77 M(+14.1%) |
| June 2016 | - | -$5.17 M(+55.6%) | -$11.19 M(+13.4%) |
| Mar 2016 | - | -$3.32 M(+22.9%) | -$9.86 M(-29.2%) |
| Dec 2015 | -$8.95 M(-8.2%) | - | - |
| Oct 2015 | - | -$2.70 M(-29.7%) | -$13.94 M(-1.5%) |
| July 2015 | - | -$3.84 M(+136.1%) | -$14.15 M(+15.1%) |
| Apr 2015 | -$9.75 M(+5.3%) | -$1.63 M(-36.0%) | -$12.29 M(+15.3%) |
| Mar 2015 | - | -$2.54 M(-21.2%) | -$10.66 M(-3.9%) |
| Jan 2015 | - | -$3.23 M(+10.8%) | -$11.10 M(+4.9%) |
| Oct 2014 | - | -$2.91 M(+46.9%) | -$10.58 M(+9.3%) |
| July 2014 | - | -$1.98 M(-33.5%) | -$9.68 M(+4.5%) |
| Apr 2014 | -$9.26 M(+88.2%) | -$2.98 M(+10.2%) | -$9.26 M(+19.9%) |
| Jan 2014 | - | -$2.71 M(+34.4%) | -$7.72 M(+34.2%) |
| Oct 2013 | - | -$2.01 M(+28.8%) | -$5.76 M(+18.2%) |
| July 2013 | - | -$1.56 M(+8.5%) | -$4.87 M(-1.0%) |
| Apr 2013 | -$4.92 M(-40.6%) | -$1.44 M(+94.9%) | -$4.92 M(+0.4%) |
| Jan 2013 | - | -$739.00 K(-34.5%) | -$4.90 M(-23.8%) |
| Oct 2012 | - | -$1.13 M(-30.0%) | -$6.44 M(-17.9%) |
| July 2012 | - | -$1.61 M(+13.5%) | -$7.84 M(-5.3%) |
| Apr 2012 | -$8.28 M | -$1.42 M(-37.5%) | -$8.28 M(-3.8%) |
| Jan 2012 | - | -$2.27 M(-10.1%) | -$8.61 M(+0.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2011 | - | -$2.53 M(+23.2%) | -$8.60 M(+9.6%) |
| July 2011 | - | -$2.05 M(+17.3%) | -$7.84 M(-6.7%) |
| Apr 2011 | -$8.40 M(-2.1%) | -$1.75 M(-22.6%) | -$8.40 M(-6.1%) |
| Jan 2011 | - | -$2.26 M(+27.4%) | -$8.95 M(-11.8%) |
| Oct 2010 | - | -$1.78 M(-32.0%) | -$10.14 M(+4.9%) |
| July 2010 | - | -$2.61 M(+14.0%) | -$9.67 M(+12.6%) |
| Apr 2010 | -$8.59 M(+111.6%) | -$2.29 M(-33.7%) | -$8.59 M(+12.5%) |
| Jan 2010 | - | -$3.46 M(+165.3%) | -$7.63 M(+48.9%) |
| Oct 2009 | - | -$1.30 M(-14.6%) | -$5.13 M(+8.8%) |
| July 2009 | - | -$1.53 M(+14.3%) | -$4.71 M(+16.1%) |
| Apr 2009 | -$4.06 M(+78.3%) | -$1.34 M(+39.9%) | -$4.06 M(+20.0%) |
| Jan 2009 | - | -$955.90 K(+7.4%) | -$3.38 M(-5.5%) |
| Oct 2008 | - | -$890.20 K(+1.8%) | -$3.58 M(+15.3%) |
| July 2008 | - | -$874.20 K(+32.5%) | -$3.10 M(+36.3%) |
| Apr 2008 | -$2.28 M(+100.1%) | -$660.00 K(-42.7%) | -$2.28 M(+28.0%) |
| Jan 2008 | - | -$1.15 M(+176.9%) | -$1.78 M(+59.0%) |
| Oct 2007 | - | -$415.90 K(+752.3%) | -$1.12 M(+17.6%) |
| July 2007 | - | -$48.80 K(-69.8%) | -$951.20 K(-16.4%) |
| Apr 2007 | -$1.14 M(-47.0%) | -$161.70 K(-67.1%) | -$1.14 M(-11.8%) |
| Jan 2007 | - | -$491.90 K(+97.7%) | -$1.29 M(-3.7%) |
| Oct 2006 | - | -$248.80 K(+5.8%) | -$1.34 M(-18.4%) |
| July 2006 | - | -$235.20 K(-25.0%) | -$1.64 M(-23.6%) |
| Apr 2006 | -$2.15 M(+7.9%) | -$313.70 K(-42.0%) | -$2.15 M(-11.8%) |
| Jan 2006 | - | -$541.20 K(-1.7%) | -$2.44 M(-4.9%) |
| Oct 2005 | - | -$550.70 K(-25.9%) | -$2.56 M(+5.4%) |
| July 2005 | - | -$742.70 K(+23.3%) | -$2.43 M(+22.1%) |
| Apr 2005 | -$1.99 M(+12.3%) | -$602.30 K(-9.6%) | -$1.99 M(+4.6%) |
| Jan 2005 | - | -$666.60 K(+58.5%) | -$1.90 M(+12.6%) |
| Oct 2004 | - | -$420.50 K(+39.0%) | -$1.69 M(-0.7%) |
| July 2004 | - | -$302.60 K(-41.2%) | -$1.70 M(-4.0%) |
| Apr 2004 | -$1.77 M(-15.3%) | -$514.50 K(+13.5%) | -$1.77 M(+11.0%) |
| Jan 2004 | - | -$453.40 K(+4.8%) | -$1.60 M(-1.8%) |
| Oct 2003 | - | -$432.70 K(+16.0%) | -$1.63 M(-23.9%) |
| July 2003 | - | -$372.90 K(+10.2%) | -$2.14 M(+2.1%) |
| Apr 2003 | -$2.09 M(+10.3%) | -$338.40 K(-30.0%) | -$2.09 M(-128.0%) |
| Jan 2003 | - | -$483.30 K(-48.8%) | $7.47 M(-428.8%) |
| Oct 2002 | - | -$943.10 K(+186.7%) | -$2.27 M(+27.5%) |
| July 2002 | - | -$328.90 K(-103.6%) | -$1.78 M(-6.1%) |
| Apr 2002 | -$1.90 M(+23.4%) | $9.23 M(-190.2%) | -$1.90 M(-83.6%) |
| Jan 2002 | - | -$10.23 M(+2160.6%) | -$11.57 M(+519.9%) |
| Oct 2001 | - | -$452.40 K(+1.6%) | -$1.87 M(+5.1%) |
| July 2001 | - | -$445.10 K(+0.8%) | -$1.78 M(+15.5%) |
| Apr 2001 | -$1.54 M(+68.4%) | -$441.50 K(-16.2%) | -$1.54 M(+9.1%) |
| Jan 2001 | - | -$526.70 K(+45.3%) | -$1.41 M(+19.2%) |
| Oct 2000 | - | -$362.50 K(+75.2%) | -$1.18 M(+28.5%) |
| July 2000 | - | -$206.90 K(-34.0%) | -$920.20 K(+0.8%) |
| Apr 2000 | -$913.30 K(+14.2%) | -$313.30 K(+4.4%) | -$913.30 K(+52.2%) |
| Jan 2000 | - | -$300.00 K(+200.0%) | -$600.00 K(+100.0%) |
| Oct 1999 | - | -$100.00 K(-50.0%) | -$300.00 K(+50.0%) |
| July 1999 | - | -$200.00 K | -$200.00 K |
| Apr 1999 | -$800.00 K(+39.0%) | - | - |
| Apr 1998 | -$575.70 K(-34.0%) | - | - |
| Apr 1997 | -$872.10 K(-43.0%) | - | - |
| Apr 1996 | -$1.53 M | - | - |
FAQ
- What is Tenax Therapeutics annual cash flow from operations?
- What is the all time high annual CFO for Tenax Therapeutics?
- What is Tenax Therapeutics annual CFO year-on-year change?
- What is Tenax Therapeutics quarterly cash flow from operations?
- What is the all time high quarterly CFO for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly CFO year-on-year change?
- What is Tenax Therapeutics TTM cash flow from operations?
- What is the all time high TTM CFO for Tenax Therapeutics?
- What is Tenax Therapeutics TTM CFO year-on-year change?
What is Tenax Therapeutics annual cash flow from operations?
The current annual CFO of TENX is -$5.90 M
What is the all time high annual CFO for Tenax Therapeutics?
Tenax Therapeutics all-time high annual cash flow from operations is -$575.70 K
What is Tenax Therapeutics annual CFO year-on-year change?
Over the past year, TENX annual cash flow from operations has changed by +$5.49 M (+48.16%)
What is Tenax Therapeutics quarterly cash flow from operations?
The current quarterly CFO of TENX is -$3.09 M
What is the all time high quarterly CFO for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly cash flow from operations is $9.23 M
What is Tenax Therapeutics quarterly CFO year-on-year change?
Over the past year, TENX quarterly cash flow from operations has changed by +$2.08 M (+40.23%)
What is Tenax Therapeutics TTM cash flow from operations?
The current TTM CFO of TENX is -$12.46 M
What is the all time high TTM CFO for Tenax Therapeutics?
Tenax Therapeutics all-time high TTM cash flow from operations is $7.47 M
What is Tenax Therapeutics TTM CFO year-on-year change?
Over the past year, TENX TTM cash flow from operations has changed by -$3.11 M (-33.33%)